
Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer
Keywords: نئوپلاسم یا تومور پستان; Breast neoplasms; Randomised controlled trials; Antineoplastic combined chemotherapy protocols; Epirubicin; Cyclophosphamide; Methotrexate; Fluorouracil; Survival analysis; Proportional hazards models;